Partially as a result of the COVID-19 pandemic, patients have demonstrated increasing interest in addressing health care issues from their homes, through telehealth visits with their doctors, or home-based screening, testing, or monitoring devices. Continuous glucose monitors (CGMs) help patients self-manage their diabetes from home. This presentation will address a professional practice gap in knowledge about the broader use of CGMs in primary care patients with type 2 diabetes, addressing patient preference for home-based self-management technology, as well as a broader application of CGMs, i.e., prior to insulin therapy initiation.

Read on my.amga.org

Welcome to the age of constraints, most cannot afford either the cost or deployment time of large complex systems, you likely already own platform automation capabilities that can drive impact toward transformative healthcare outcomes. This discussion will focus on how your data can drive the automation of outcomes that quickly align with the principles of the quintuple aim and create the agility to address future challenges. 

Read on chimecentral.org

Over the past couple of years, the engineered biology market has seen fledgling companies rise to IPO smashing power players, as the demand for high-quality, engineered biomolecules and controllable therapeutics grows exponentially.

The therapeutic potential of novel synthetic units is huge, but challenges remain in demonstrating proof-of-concept, developing assays, functional characterization, manufacturing scale-up, and identifying therapeutic applications for commercial development.

Returning for the 2nd year, the Synthetic Biology-Based Therapies Summit is the industry-defining forum made exclusively for leaders in the synthetic and engineered biology space, focusing on the technical challenges that lie ahead in the path towards commercialization.

Learn from industry trailblazers at Arsenal Biosciences, bit.bio, MIT, Novome Bio, Strand Therapeutics, Synlogic and more, to support your efforts in developing safe and effective synthetic biology-based therapeutics.

Prices:

Conference + Workshop Day - Industry Pricing USD 3497.00

Conference Only - Industry Pricing USD 2599.00

Conference + Workshop Day - Service Provider Pricing USD 4297.00

Conference Only - Service Provider Pricing USD 3199.00

Conference + Workshop Day - Academic Pricing USD 2897.00

Conference Only - Academic Pricing USD 2199.00

Category: Conferences | Science, Health & Medicine | Pharmaceuticals | Drug Development

Dates and Time: Starts: Tue, Dec 13, 2022 ( 9:00 AM) and Ends: Thu, Dec 15, 2022 ( 5:00 PM)

Venue details: Embassy Suites by Hilton Boston at Logan Airport, 207 Porter Street, Boston, Massachusetts, 02128, United States

Over the past four months, through a partnership with the Korean Startup Center (KSC), IntuitiveX alongside University of Washington - CoMotion and Washington Technology Innovation Alliance (WTIA) have been providing five Korean companies with strategic guidance, resources and a cohort of mentors to support with their commercialization efforts within the U.S. as they prepare for U.S. market entry.

On December 13, join us for an in-person and virtual showcase where the following five companies Deep Bio, Olive Healthcare, VNTC, Orange Biomed, and Mezoo will share how their novel healthcare technologies are driving innovation to solve unmet challenges in healthcare. After the pitches, join us for networking and discussion. This will be an opportunity to connect with the five Korean startups and identify opportunities to collaborate with them as potential customers, strategic partners, advisors, and more.

Read on eventbrite.com

In 2022, the International Atomic Energy Agency (IAEA) will hold the International Conference on Integrated Medical Imaging in Cardiovascular Diseases (IMIC-2022), building on the success of the IMIC-2013 and IMIC-2016 conferences. Non-communicable diseases (NCDs) are steadily increasing both in developed and developing countries. Cardiovascular diseases (CVDs) are a dominant subgroup of NCDs and account for the highest proportional mortality among all NCDs.

Read on iaea.org

Electronic Health Record (HER) alerts may help bridge the 17-year gap between publication of evidence-based guidelines and consistent implementation in practice by healthcare providers. The Pragmatic Trials of Messaging to Providers about Treatment (PROMPT) studies are investigating the use of informational alerts within the (EHR) to providers that inform them of FDA approved, evidence-based therapies for patients who meet certain inclusion criteria. Dr. Riello will highlight key takeaways from the PROMPT-HF trial and present the results of PROMPT-LIPID trial, recently shared for the first time as a late-breaking clinical trial at the American Heart Association Scientific Sessions on November 6. The PROMPT-HF trial results show that prescribers who viewed the Best Practice Advisory (BPA) were 41% more likely to consider prescribing an additional guideline-directed medical therapy class and 79% of alerted providers in the PROMPT-HF trial agreed that the alert was effective. Was the PROMPT-LIPID alert effective at improving adherence to AHA/ACC guidelines for lipid-lowering therapies?

Key Takeaways:

• Adherence to clinical guidelines is difficult to establish, taking roughly 17 years from publication to implementation 
• EHR alerts may help bridge the gap between evidence-based guidelines and real-world practice
• Seventy-nine percent of alerted providers in the PROMPT-HF trial agreed that the alert was effective at enabling improved prescription of guideline-directed medical therapies for heart failure 
• EHR alerts may improve awareness and adherence to AHA/ACC guidelines for lipid-lowering therapies

Read on my.amga.org

As the future of U.S. healthcare continues to evolve, the 20th Annual Washington Health Law Summit (WHS) is the one event you can’t afford to miss! It is essential for advisors in all segments of the healthcare industry to stay up-to-date on the latest legislative and policy developments, as well as the implementation of significant healthcare initiatives emanating from the federal government, including Health and Human Services, Centers for Medicare and Medicaid Services, the Department of Justice, the Office of the Inspector General, and other vital agencies.

Read on web.cvent.com

Join Novant Health executives and community partners for A Night at the Innovation Lab -- a social event with experiential innovations from across Novant Health on December 12th from 5:00 – 7:30. Novant Health is opening a second Innovation Lab in Wilmington in 2023 and this event will showcase the experiences we’ll host there. Try a virtual reality experience to manage anxiety, battle virtual pain receptors, and work on meditation skills. Or view some of our cutting-edge platforms including 3D printing, augmented reality, AI-empowered imaging, robots, remote patient monitoring technology, and more. Learn about our Novant Health internal employee Innovation Ambassador program, gain insights on how to work with the Lab team develop IP and create new products and services, and hear more about our forthcoming podcast and youth STEM engagement programs.

Read on eventbrite.com

This program will be presented live in-person on Marco Island, FL and also is available via livestream Eastern Daylight Time zone.

The program seeks to address competence in using multiple echocardiographic techniques in assessment of cardiac structure and function in adult acquired or congenital heart disease. This will include concise, limited didactic lectures with major emphasis on a series of illustrative cases which will include audience response and discussion presented by echocardiography specialists which would lead to enhanced patient management. Workshops will be held to demonstrate the techniques for acquiring the echocardiographic data, especially with respect to new contemporary techniques such as strain imaging.

Access to course recordings for one year with registration.

Time: 07:00 to 12:00

John Wageman joined the CDE team in April as the 3D Printing Sales Representative, where he serves as the company’s 3D printing specialist. John provides a vast knowledge of the dental industry spanning 30 years. From his early work in the dental laboratory industry, he can directly attest to the advancement and precision of dental imaging and 3D printing through the years. His career includes dental lab management starting in the U.S. Army and years of sales in a variety of different technologies roles.

Read on eventbrite.co.uk